[PET technology: Latest advances and potential impact on radiotherapy].

Tomographie par émission de positons (TEP) pour la radiothérapie : technique et innovations.

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 27 05 2020
revised: 17 07 2020
accepted: 21 07 2020
pubmed: 31 8 2020
medline: 9 10 2020
entrez: 31 8 2020
Statut: ppublish

Résumé

Multimodal imaging has become a standard for planning radiation therapy via magnetic resonance imaging (MRI) or positron emission tomography (PET) in many cancers. However, its use is now old, and its impact has not been much discussed in light of technological improvements in imaging and advances in radiotherapy. However, in 20 years, the exclusive functional imaging has been replaced by hybrid imaging (functional and anatomical) with successive improvements (flight time, detector modifications, digitisation, etc.) have enabled us to go from centimetric resolution to the current 3 to 4mm resolution. This article will specifically review PET technology, its latest advances and the potential impact on radiotherapy, particularly head and neck cancers.

Identifiants

pubmed: 32861609
pii: S1278-3218(20)30197-9
doi: 10.1016/j.canrad.2020.07.006
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

628-634

Informations de copyright

Copyright © 2020. Published by Elsevier Masson SAS.

Auteurs

P Decazes (P)

Département de médecine nucléaire, centre Henri-Becquerel, 1, rue d'Amiens, 76038 Rouen, France; QuantIF-Litis, EA 4108, faculté de médecine, université de Rouen, 22, boulevard Gambetta, 76000 Rouen, France.

S Hapdey (S)

Département de médecine nucléaire, centre Henri-Becquerel, 1, rue d'Amiens, 76038 Rouen, France; QuantIF-Litis, EA 4108, faculté de médecine, université de Rouen, 22, boulevard Gambetta, 76000 Rouen, France.

A Larnaudie (A)

Département de radiothérapie, centre François Baclesse, ARCHADE, 3, avenue General-Harris, 14000 Caen, France.

J Thariat (J)

Département de radiothérapie, centre François Baclesse, ARCHADE, 3, avenue General-Harris, 14000 Caen, France; Laboratoire de physique corpusculaire, IN2P3/ENSICAEN, UMR6534, Caen, France; Unicaen, Normandie université, France.

S Thureau (S)

Département de médecine nucléaire, centre Henri-Becquerel, 1, rue d'Amiens, 76038 Rouen, France; QuantIF-Litis, EA 4108, faculté de médecine, université de Rouen, 22, boulevard Gambetta, 76000 Rouen, France; Département de radiothérapie et de physique médicale, centre Henri-Becquerel, 1, rue d'Amiens, 76038 Rouen, France. Electronic address: sebastien.thureau@chb.unicancer.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH